Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-25 @ 9:20 PM
Study NCT ID:
NCT06050356
Status:
RECRUITING
Last Update Posted:
2025-05-13
First Post:
2023-09-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b
Sponsor:
Statens Serum Institut
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-14
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-17
First Submit QC Date:
None
Study First Post Date:
2023-09-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-07
Last Update Post Date:
2025-05-13
Last Update Post Date Type:
ACTUAL